TCM Bioscience Series: Defining a Successful Reimbursement Strategy
Strategic reimbursement planning is critical in today's dynamic health care environment. Navigating the changes in reimbursement policies and issues in the earliest stages of product development is vital to the success of new pharmaceuticals, medical devices, diagnostics, and, ultimately, to the success of a company. Regulatory approval, provider economics and the increased role of third-party payers has increased the pressure on manufacturers to deliver and communicate the value of new technologies to the wider health care system.
From coding, to coverage, to payment, join us as we learn from an expert panel about what you need to know to strategically position your products to maximize market impact.
Program topics include:
- Why early-stage bioscience companies need to make reimbursement a part of the overall business strategy.
- The impact of the current reimbursement landscape on your product.
- Best practices for crafting a value message to payers.
- From clinic to market, how to develop appropriate coverage, coding, and payment strategies.